Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Equity: 2021-2025

Historic Return on Equity for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to -0.24%.

  • Legend Biotech's Return on Equity rose 6.00% to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -0.15% for FY2024, which is 36.00% up from last year.
  • Legend Biotech's Return on Equity amounted to -0.24% in Q3 2025, which was up 24.05% from -0.31% recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Return on Equity ranged from a high of -0.03% in Q3 2023 and a low of -1.28% during Q2 2021.
  • Its 3-year average for Return on Equity is -0.32%, with a median of -0.30% in 2024.
  • In the last 5 years, Legend Biotech's Return on Equity spiked by 43bps in 2022 and then slumped by 31bps in 2023.
  • Legend Biotech's Return on Equity (Quarterly) stood at -0.61% in 2021, then soared by 43bps to -0.44% in 2022, then slumped by 31bps to -0.40% in 2023, then rose by 24bps to -0.16% in 2024, then grew by 6bps to -0.24% in 2025.
  • Its Return on Equity stands at -0.24% for Q3 2025, versus -0.31% for Q2 2025 and -0.21% for Q1 2025.